Benign gallbladder disease
Conditions
Interventions
A1:The intervention consisted of an intravenous injection of 0.25 mg ICG, administered within the window of 0 to 3 hours before the laparoscopic cholecystectomy.
A2:The intervention consisted of an intravenous injection of 0.50 mg ICG, administered within the window of 0 to 3 hours before the laparoscopic cholecystectomy.
A3:The intervention consisted of an intravenous injection of 1.00 mg ICG, administered within the window of 0 to 3 hours before the laparoscopic cholecystectomy.
A4:The intervention consisted of an intravenous injection of 2.50 mg ICG, administered within the window of 0 to 3 hours before the laparoscopic cholecystectomy.
A5:The intervention consisted of an intravenous injection of 0.25 mg ICG, administered within the window of 3 to 6 hours before the laparoscopic cholecystectomy.
A6:The intervention consisted of an intravenous injection of 0.50 mg ICG, administered within the window of 3 to 6 hours before the laparoscopic cholecystectomy.
A7:The intervention consisted of an intravenous injection of 1.00 mg ICG, administered within the window of 3 to 6 hours before the laparoscopic cholecystectomy.
A8:The intervention consisted of an intravenous injection of 2.50 mg ICG, administered within the window of 3 to 6 hours before the laparoscopic cholecystectomy.
A9:The intervention consisted of an intravenous injection of 0.25 mg ICG, administered within the window of 6 to 9 hours before the laparoscopic cholecystectomy.
A10:The intervention consisted of an intravenous injection of 0.50 mg ICG, administered within the window of 6 to 9 hours before the laparoscopic cholecystectomy.
A11:The intervention consisted of an intravenous injection of 1.00 mg ICG, administered within the window of 6 to 9 hours before the laparoscopic cholecystectomy.
A12:The interven
Sponsors
Shijiazhuang People’s Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 85 Years
Inclusion criteria
Inclusion criteria: 1. Participants must be adults aged between 18 and 85 years with complete clinical data; 2. Preoperative diagnosis of benign gallbladder disease must be established through detailed medical history, physical examination, and at least one auxiliary imaging modality (e.g., abdominal ultrasound, CT, or MRI); 3. Patients must meet the indications for laparoscopic cholecystectomy; 4. Child-Pugh classification must be Grade A; 5. Patients should not undergo any other abdominal surgery during the current hospitalization.
Exclusion criteria
Exclusion criteria: 1. History of allergy to iodine or indocyanine green; 2. Liver function classified as Child-Pugh B or C; 3. Patients with severe coagulopathy or poor cardiopulmonary function, unable to tolerate surgery or anesthesia; 4. Biliary obstruction or bile metabolism disorder; 5. Presence of malignant tumors in the gallbladder or liver.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The bile duct-to-liver fluorescence contrast ratio;Subjective success rate of visualization; | — |
Secondary
| Measure | Time frame |
|---|---|
| Operation time;Blood loss; | — |
Countries
China
Contacts
Public ContactGu Jianbin
Shijiazhuang People’s Hospital
Outcome results
None listed